Code from: The retinal age gap: An affordable and highly accessible biomarker for population-wide disease screening across the globe
Version 1Traditional biomarkers, such as those obtained from blood tests, are essential for early disease detection, improving health outcomes, and reducing healthcare costs. However, they often involve invasive procedures, specialized laboratory equipment, or special handling of biospecimens. The retinal age gap (RAG) has emerged as a promising new biomarker that can overcome these limitations, making it particularly suitable for disease screening in low- and middle-income countries. This study a
No license available
Traditional biomarkers, such as those obtained from blood tests, are essential for early disease detection, improving health outcomes, and reducing healthcare costs. However, they often involve invasive procedures, specialized laboratory equipment, or special handling of biospecimens. The retinal age gap (RAG) has emerged as a promising new biomarker that can overcome these limitations, making it particularly suitable for disease screening in low- and middle-income countries. This study a